Polycystic Ovary Syndrome (Disease Or Phenotype)

Omim:184700

Nci:C26862

Msh:D011085

Mondo:MONDO:8487

Medcin:MEDCIN:30469

Mdr:MDR:10036049

Id:34217022-1b8f-599d-aec6-ecf10dca0e7a

Icpc2icd10eng:MTHU056754

Icd10cm:E28.2

Efo:EFO:660

Doid:DOID:11612

Chv:CHV:9909

Linked to

	Label	Description
	10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione correlated with condition Polycystic Ovary Syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Dehydroepiandrosterone Sulfate correlated with condition Polycystic Ovary Syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	androstenedione correlated with condition Polycystic Ovary Syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics

10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione correlated with condition Polycystic Ovary Syndrome

A Knowledge Graph Assertion from Metabolomics

Dehydroepiandrosterone Sulfate correlated with condition Polycystic Ovary Syndrome

A Knowledge Graph Assertion from Metabolomics

androstenedione correlated with condition Polycystic Ovary Syndrome

A Knowledge Graph Assertion from Metabolomics

DISPLAY PER PAGE

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025